Basic information Safety Supplier Related
ChemicalBook >  Product Catalog >  Pharmaceutical intermediates >  Heterocyclic compound >  Pyridine compound >  Nitropyridine >  2-Chloro-5-iodo-3-nitropyridine

2-Chloro-5-iodo-3-nitropyridine

Basic information Safety Supplier Related

2-Chloro-5-iodo-3-nitropyridine Basic information

Product Name:
2-Chloro-5-iodo-3-nitropyridine
Synonyms:
  • Pyridine, 2-chloro-5-iodo-3-nitro-
  • 2-Chloro-5-iodo-3-nitropy...
  • 2-Chloro-3-nitro-5-iodopyridine
  • 2-Chloro-5-iodo-3-nitropyridine ISO 9001:2015 REACH
CAS:
426463-05-0
MF:
C5H2ClIN2O2
MW:
284.44
Mol File:
426463-05-0.mol
More
Less

2-Chloro-5-iodo-3-nitropyridine Chemical Properties

Melting point:
77-81 °C
Boiling point:
334.0±37.0 °C(Predicted)
Density 
2.213±0.06 g/cm3(Predicted)
storage temp. 
under inert gas (nitrogen or Argon) at 2–8 °C
pka
-4.74±0.10(Predicted)
form 
solid
Appearance
Off-white to gray Solid
InChI
InChI=1S/C5H2ClIN2O2/c6-5-4(9(10)11)1-3(7)2-8-5/h1-2H
InChIKey
PIJMRJPJERUFNI-UHFFFAOYSA-N
SMILES
C1(Cl)=NC=C(I)C=C1[N+]([O-])=O
More
Less

Safety Information

Hazard Codes 
Xn
Risk Statements 
22-37/38-41
Safety Statements 
26-36/37/39
WGK Germany 
3
HS Code 
2933599590
More
Less

2-Chloro-5-iodo-3-nitropyridine Usage And Synthesis

Uses

2-Chloro-5-iodo-3-nitropyridine is used in preparation of nitrogen heterocycles as colony stimulating factor-1 receptor (CSF-1R) inhibitors.

Synthesis

25391-57-5

426463-05-0

b) General procedure for the synthesis of 2-chloro-5-iodo-3-nitropyridine from 2-amino-5-iodo-3-nitropyridine: 5-iodo-3-nitropyridin-2-amine (1.3 g, 4.9 mmol) was dissolved in concentrated hydrochloric acid at 0 °C, followed by slow addition of sodium nitrite (6.73 g, 97.13 mmol). Next, a solution of 20 molar equivalents of copper (I) bromide was added dropwise, followed by copper (I) chloride (0.5 g, 4.9 mmol, 1 equiv). The reaction mixture was stirred at room temperature for 12 hours. Upon completion of the reaction, the mixture was poured into a mixture of ammonium hydroxide and water (1:1, v/v) and extracted with ethyl acetate (3 x 150 mL). The organic phases were combined and washed sequentially with water, aqueous sodium thiosulfate and saturated saline, and dried over anhydrous sodium sulfate. The solvent was removed by distillation under reduced pressure to afford the target product 2-chloro-5-iodo-3-nitropyridine in 43% (0.6 g) yield.

References

[1] Patent: WO2013/53983, 2013, A1. Location in patent: Page/Page column 37
[2] Patent: US2015/11548, 2015, A1. Location in patent: Paragraph 0153
[3] Journal of Medicinal Chemistry, 2002, vol. 45, # 21, p. 4755 - 4761
[4] Patent: US6538010, 2003, B1

2-Chloro-5-iodo-3-nitropyridineSupplier

Hangzhou Bingochem Co., Ltd. Gold
Tel
0571-8512-5372
Email
sales@bingochem.com
Nantong Xiaochang Pharmaceutical Trading Co., Ltd. Gold
Tel
0513-82104991 18912868361
Email
sales11@btcpharm.com
Energy Chemical
Tel
021-021-58432009 400-005-6266
Email
sales8178@energy-chemical.com
Shanghai Sunway Pharmaceutical Technology Co., Ltd
Tel
18270980682
Email
mlcheng@sunwaypharm.cn
Nanjing Vital Chemical Co., Ltd.
Tel
Please Send Email 18652950785
Email
chemweiao@163.com